Drug recall D-0097-2023
Product
Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,
Reason for recall
Lack of assurance of sterility: Bags have the potential to leak.
Lots and codes
Lot: 5935283, Exp. 12/01/2023
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 62,088 bags
- Distribution
- Nationwide in the USA.
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 29, 2022
Related products
- Heparin Sodium – drug information
- NDC 0409-1005 Heparin Sodium · Heparin Sodium 200 [USP'U]/100mL · Hospira, Inc.
- NDC 0409-2222 Heparin Sodium · Heparin Sodium 200 [USP'U]/100mL · Hospira, Inc.